Gene transfer of the Ly-3 chain gene of the mouse CD8 molecular complex: co-transfer with the Ly-2 polypeptide gene results in detectable cell surface expression of the Ly-3 antigenic determinants.

The CD8 molecule is a glycoprotein expressed on a subset of mature T lymphocytes. It has been postulated to be a receptor for class I major histocompatibility complex molecules. In the mouse, CD8 is a heterodimer composed of Ly-2 and Ly-3 chains. We have isolated and analyzed cDNA and cosmid clones corresponding to the Ly-3 subunit. One of the isolated, cosmid clones was subsequently transfected, alone or in combination with the Ly-2 gene, into mouse Ltk- cells. Analysis of the Ly-2,3 molecules expressed at the surface of the double transfectants indicated that they are serologically and biochemically indistinguishable from their normal counterparts expressed on lymphoid cells. Ltk- cells transfected with the Ly-2 gene alone were shown to react with a subset of anti-CD8 monoclonal antibodies whereas Ly-3 transfectants did not stain with any of the anti-Ly-3 antibodies employed in this study. Since at least one of these antibodies (53-5.8) has been previously shown to recognize an epitope which is retained on the Ly-3 subunit after dissociation of the heterodimeric Ly-2,3 complex, these observations suggest that the expression of the Ly-2 polypeptide is required to permit the detectable cell surface expression of the antigenic determinants carried by the Ly-3 subunit.

Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): a phase 2 randomised trial.

BACKGROUND: Letrozole radiosensitises breast cancer cells in vitro. In clinical settings, no data exist for the combination of letrozole and radiotherapy. We assessed concurrent and sequential radiotherapy and letrozole in the adjuvant setting. METHODS: This phase 2 randomised trial was undertaken in two centres in France and one in Switzerland between Jan 12, 2005, and Feb 21, 2007. 150 postmenopausal women with early-stage breast cancer were randomly assigned after conserving surgery to either concurrent radiotherapy and letrozole (n=75) or sequential radiotherapy and letrozole (n=75). Randomisation was open label with a minimisation technique, stratified by investigational centres, chemotherapy (yes vs no), radiation boost (yes vs no), and value of radiation-induced lymphocyte apoptosis (< or = 16% vs >16%). Whole breast was irradiated to a total dose of 50 Gy in 25 fractions over 5 weeks. In the case of supraclavicular and internal mammary node irradiation, the dose was 44-50 Gy. Letrozole was administered orally once daily at a dose of 2.5 mg for 5 years (beginning 3 weeks pre-radiotherapy in the concomitant group, and 3 weeks post-radiotherapy in the sequential group). The primary endpoint was the occurrence of acute (during and within 6 weeks of radiotherapy) and late (within 2 years) radiation-induced grade 2 or worse toxic effects of the skin. Analyses were by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00208273. FINDINGS: All patients were analysed apart from one in the concurrent group who withdrew consent before any treatment. During radiotherapy and within the first 12 weeks after radiotherapy, 31 patients in the concurrent group and 31 in the sequential group had any grade 2 or worse skin-related toxicity. The most common skin-related adverse event was dermatitis: four patients in the concurrent group and six in the sequential group had grade 3 acute skin dermatitis during radiotherapy. At a median follow-up of 26 months (range 3-40), two patients in each group had grade 2 or worse late effects (both radiation-induced subcutaneous fibrosis). INTERPRETATION: Letrozole can be safely delivered shortly after surgery and concomitantly with radiotherapy. Long-term follow-up is needed to investigate cardiac side-effects and cancer-specific outcomes. FUNDING: Novartis Oncology France.

Prevalence of substance use in a Swiss psychiatric hospital: interview reports and urine screening.

BACKGROUND: Co-morbid substance misuse is common in psychiatric disorders, has potentially severe adverse consequences and may be frequently undetected. AIMS: To measure the prevalence of substance use among patients admitted to a Swiss psychiatric hospital and to examine the potential utility of routine urine drug screening in this setting. METHOD: 266 inpatients were included. 238 patients completed the interview and 240 underwent a urine drug screening. RESULTS: Lifetime prevalence of substance use among psychiatric patients was very high for alcohol (98%; 95% CI: 96-100), benzodiazepines (86%; 95% CI: 82-91) and cannabis (53%; 95% CI: 47-60), but also for "hard drugs" like cocaine (25% ; 95% CI: 19-30) or opiates (20%; 95% CI: 15-25). Regular current use of alcohol (32%; 95% CI: 26-38) or cannabis (17%; 95% CI: 12-22) was the most frequent. Substance use was associated with male sex, younger age, unmarried status and nicotine smoking. Urine screening confirms reports from patients on recent use, and remained positive for cannabis during hospitalisation, but not for cocaine nor for opiates. CONCLUSION: Substance use is frequent among psychiatric patients. Systematic interviewing of patients about their substance use remains essential, and is usually confirmed by urine screening. Urine screening can be useful to provide specific answers about recent use.

Conflict and co-operation in ant societies

Cette thèse se propose d?étudier les forces évolutives qui influencent la bal- ance entre coopération et conflit. Deux exemples sont analysés en détail, les sociétés d?insectes et l?association entre la fourmi Formica exsecta et son sym- bionte intracellulaire Wolbachia. Chacune de ces deux associations animales est caractérisée par la coexistence de coopération et de conflit. Les colonies d?insectes sociaux sont un exemple typique de coopération. Néanmoins, la détermination haplodiploïde du sexe crée des apparentements asymétriques entre les membres de la colonie qui se traduisent par des con- flits entre reines et ouvrières. Un des conflits les plus importants porte sur le sexe-ratio, l?investissement optimal en sexués males et femelles étant équilibré pour la reine, mais biaisé en faveur des femelles pour les ouvrières. Jusqu?ici, les modèles étudiant ce conflit se basaient uniquement sur les asymétries d?ap- parentement. La première partie de cette thèse (Chapitres 1 et 2) propose d?introduire dans des modèles de sexe-ratio les mécanismes proximaux utilisés par les deux parties pour influencer le sexe-ratio. Ces mécanismes, par leurs ef- fets négatifs sur la productivité de la colonie, peuvent entraîner des déviations importantes du sexe-ratio par rapport à la valeur prédite par des modèles clas- siques. De plus, la prise en compte de ces mécanismes nous permet d?étudier dans quelle mesure les parties opposées sont sélectionnées pour influencer le sexe-ratio. Enfin, les modèles génèrent des prédictions quant à l?issue du con- flit, c?est-à-dire un compromis où reines et ouvrières partagent le contrôle de l?investissement. La seconde partie du travail porte sur l?infection de la fourmi Formica ex- secta par le symbionte cytoplasmique Wolbachia. Ce symbionte, présent chez un grand nombre d?espèces d?Arthropodes, est transmis maternellement. Afin de se répandre dans la population d?hôtes, Wolbachia manipule la physiolo- gie reproductive de l?organisme qui l?abrite. Le Chapitre 3 décrit une étude consacrée aux variations du sexe-ratio produit dans des colonies de fourmis? en fonction de la présence ou de l?absence de Wolbachia. Le Chapitre 4 étudie l?association entre les lignées du symbionte et les haplotypes mitochondriaux des hôtes. L?étude de l?association entre les deux éléments maternellement transmis est d?un intérêt particulier chez Formica exsecta car le taux de migra- tion femelle très faible engendre une forte strucure génétique mitochondriale.